Your browser doesn't support javascript.
loading
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.
Karacin, Cengiz; Eren, Tulay; Zeynelgil, Esra; Imamoglu, Goksen Inanc; Altinbas, Mustafa; Karadag, Ibrahim; Basal, Fatma Bugdayci; Bilgetekin, Irem; Sutcuoglu, Osman; Yazici, Ozan; Ozdemir, Nuriye; Ozet, Ahmet; Yildiz, Yesim; Esen, Selin Akturk; Ucar, Gokhan; Uncu, Dogan; Dinc, Bedia; Aykan, Musa Baris; Erturk, Ismail; Karadurmus, Nuri; Civelek, Burak; Çelik, Ismail; Ergun, Yakup; Dogan, Mutlu; Oksuzoglu, Omur Berna.
Afiliación
  • Karacin C; Department of Medical Oncology, Recep Tayyip Erdogan University Training & Research Hospital, Rize, Turkey.
  • Eren T; Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.
  • Zeynelgil E; Department of Medical Oncology, HSU Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey.
  • Imamoglu GI; Department of Medical Oncology, HSU Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey.
  • Altinbas M; Department of Medical Oncology, HSU Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey.
  • Karadag I; Department of Medical Oncology, HSU Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey.
  • Basal FB; Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.
  • Bilgetekin I; Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.
  • Sutcuoglu O; Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.
  • Yazici O; Department of Medical Oncology, Gazi University, Ankara, Turkey.
  • Ozdemir N; Department of Medical Oncology, Gazi University, Ankara, Turkey.
  • Ozet A; Department of Medical Oncology, Gazi University, Ankara, Turkey.
  • Yildiz Y; Department of Medical Oncology, Gazi University, Ankara, Turkey.
  • Esen SA; Department of Infectious Diseases & Clinical Microbiology, Gazi University, Ankara, Turkey.
  • Ucar G; Department of Medical Oncology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
  • Uncu D; Department of Medical Oncology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
  • Dinc B; Department of Medical Oncology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
  • Aykan MB; Department of Medical Microbiology, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
  • Erturk I; Department of Medical Oncology, HSU Gulhane Training & Research Hospital, Ankara, Turkey.
  • Karadurmus N; Department of Medical Oncology, HSU Gulhane Training & Research Hospital, Ankara, Turkey.
  • Civelek B; Department of Medical Oncology, HSU Gulhane Training & Research Hospital, Ankara, Turkey.
  • Çelik I; Department of Medical Oncology, A Life Hospital, Ankara, Turkey.
  • Ergun Y; Department of Preventive Oncology, Institute of Oncology, Hacettepe University, Ankara, Turkey.
  • Dogan M; Department of Medical Oncology, Batman Training & Research Hospital, Batman, Turkey.
  • Oksuzoglu OB; Department of Medical Oncology, HSU Dr Abdurrahman Yurtaslan Oncology Training & Research Hospital, Ankara, Turkey.
Future Oncol ; 17(33): 4447-4456, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34342517
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido